🇺🇸 FDA
Patent

US 11813335

Pyrrolobenzodiazepine-antibody conjugates

granted A61KA61K31/5517A61K45/06

Quick answer

US patent 11813335 (Pyrrolobenzodiazepine-antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/5517, A61K45/06, A61K47/68035, A61K47/6849